openPR Logo
Press release

Helix Announces Research and Clinical Auditing Services Worldwide

05-23-2011 08:58 AM CET | Health & Medicine

Press release from: Helix Research Center Ltd

Research,Healthcare,Consulting,Training

Research,Healthcare,Consulting,Training

Since Human Life is most precious and under no circumstances any kind of harm to Human Body and /or Mind are forgiven either on Moral or Legal grounds, any Healthcare or Clinical Research Services Provider must always strive hard to ensure Utmost Quality Services,Protection of Human Rights,Confidentiality of Medical Information ,Safety and well being of the Patients/Clinical Trial Subjects.More over,as Healthcare is included under 'Essential Services Act' in any country,even inadvertent breach to the same invariably results huge loss in terms of Credibility and Money to any Stakeholder;Government,Private or Voluntary, of Healthcare and Medical Research Services.It is obvious, any Enterprise ,would expect substantial returns for the Investment made to create State of the Art Infrastructure to endure and survive the competition in the Global Healthcare/Research arena and hence there is a dire need to create and sustain a strong effective System that assures Inernational Standard Services to the Patients,Clients etc.Inorder to assist the various Hospital Managements and Clinical Research Industry, to achieve their goals to offer superlative Quality Services and /or enhance their existing capabilities,Helix Research Center has taken an initiative to offer Clinical and Research Auditing Services for the Stakeholders of Healthcare and Biopharmaceutical,Medical Device and Cosmetic R&D Industry Worldwide.

As any healthcare provider across the globe is aware,Clinical Audit- a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criteria and the implementation of change ( Principles for Best Practices in Clinical Audit-2002,NICE/CHI), was introduced by Lady With a Lamp;Florence Nightingale in the year 1855 during the Crimea War to improve the Healthcare facilities for injured Soldiers at Scutari Medical Barracks.Introduction of 'End of Plan Idea' by the great American Physician Ernest Codman in the year 1912 and Publication of his own Hospital results ; 'A Study in Hospital Efficiency' in the year 1916 ,must have prompted American College of Surgeons in the year 1918 to introduce 'Hospital Standardisation Program ' that had provided Accreditation Criteria and Standards ,which were later adopted by Joint Commission on Accreditation of Hospitals.Likewise,many countries across the World have contributed their share to define the Quality Standards in Healthcare Delivery.The persistent,consistent and relentless efforts of World Health Organisation to promote Quality Healthcare and the WHO definition 'Health is a state of complete physical,mental and social well being and not merely the absence of disease or infirmity' is familiar to the World Community and Healthcare Providers.

Research-' a structured activity which is intended to provide new knowledge,which is generalisable
( that is of value to others in a similar situation) and intended for wider dissemination'- Department of Health,UK ,2002),Scientific or Therapeutic is had been one of the most 'Controversial' Scientific activity but most essential part of New Drug Discovery Process.The Stakeholders of Clinical Research;the Clinical/Non Clnical Trial Sponsors,Clinical Research Investigators and their Support staff,Contract Research Organisations,Site Management Organisations/Trial Management Organisations,Ethics Committees etc must always strive hard to ensure strict adherence to Good Clinical Practices and Comply with Regulations Governing Medical Reseach and produce Quality Data .Since every R&D endeavour potentially can end up as a futile exercise and huge expenditure is incurred by the Sponsors to promote Research Development activities,there is no excuse for any Error or Misconduct during a Clinical Trial.Inspite of all the precautions being taken at every level of Clinical Trial Process,most of the Regulatory Inspections at the Investigative Sites of any Therapeutic area fail to achieve ' No Action Needed' remark by Inspectors.

The Clinical and Research Auditors of Helix Research Center Ltd are Senior Clinicians and Clinical Research Professionals with vast experience in their area of expertise.Most of the Research Auditors had worked for the Regulatory Authorities in the USA,Canada,EU,Oceania,Asia and Africa and Latin America.The Auditing Services are available for prospective Clients in any geographical region and Audit Reports can be provided in over 80 Languages.Apart from conducting Quality Audits,Helix Provides Consulting Services to expedite the Corrective Actions including Training the Hospital Staff or Clinical Research Teams.Helix also provides Promotional Services for Hospitals,( Medical Tourism)Pharma,Biotech,Device,Cosmetic companies and assists enthusiastic Groups,Organisations,Entrepreneurs to establish Healthcare of Medical Research Services Units.

Helix is always keen to work with like minded groups,Commercial,Academic or Voluntary/Philanthropic Organisations to promote Research and Development and Preventive/Curative Healthcare and Conduct Continuing Research and Medical Education Programs,Seminars and Conferences Pan World.

Helix Research Center Ltd is a London ,UK headquartered MNC,Providing Clinical Research,Healthcare ,Consulting and Training Services for the Prospective clients Worldwide.

Helix Research Center Ltd
Office 4 ,219 Kesington high street,
W8 6 BD,London
UK

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Helix Announces Research and Clinical Auditing Services Worldwide here

News-ID: 176133 • Views:

More Releases from Helix Research Center Ltd

Clinical Research Practices Concept to Expedite Global Clinical Trials
Clinical Research Practices Concept to Expedite Global Clinical Trials
Having analysed and understood the Non Clinical & Clinical Trial outsourcing trends in the Global Clinical Research arena and the challenges by being endured by the stakeholders of Research & Development Industry;Viz the Pharmaceutical,Medical Device,Biotechnology and Cosmetic Industry Worldwide , the issues such as Financial constraints,safety and well being of Trial subjects,Errors,Misconducts,negative talk about the Clinical Trial activity itself in one or the other media and the need for introducing
Harmonised GCP Training Courses Launched by Helix Research Center
Harmonised GCP Training Courses Launched by Helix Research Center
Inspired by the initiative of Sponsors of ICH ( International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals of Human Use) Viz,European Agency for the Evaluation of Medicinal Products ( EMEA),Japanese Ministry of Health,Labour and Welfare (JMHLW) and the US Food and Drug Administration (USFDA) , the Co Sponsors;Viz ,the European Federation of Pharmaceutical Industries' Associations (EFPIA),the Japanese Pharmaceutical Manufacturers Association (JPMA),the Pharmaceutical Research and Manufacturers of
Clinical Research Certificate Programs With Internship In India
Clinical Research Certificate Programs With Internship In India
It is an established fact that Clinical Research Industry is considered multibillion dollar industry and there can be no 'Recession' for the rapidly increasing dreadful diseases that cause high mortality and morbidity in almost every region of the World,irrespective any global economic slowdown/recession. But the Global Biopharmaceutical ,Medical Device and Cosmetic Industry and other Sponsors of R&D ( Research and Development) have been enduring many constraints including severe financial
Consulting,SMO & Site Support Services for the Global Clinical Trials
Consulting,SMO & Site Support Services for the Global Clinical Trials
In view of the absolute necessity to ensure ,Safety and well being of Clinical Trial Subjects ,strict adherence to Good Clinical Practices Guidelines and Regulations governing Biomedical Research by Doctors of various Therapeutic areas such as Cardiology,Neurology,Oncology,Endocrinology,Pulmonology,Psychiatry,Obstetrics & Gynecology,Gastroenterology,Opthalmology,ENT,Internal Medicine,General Surgery etc,the need to produce quality data for a given study,reduce Regulatory delays,prevent avoidable errors and misconducts during a Clinical Trial,reduce the avoidable overheads for the Clinical Trial Sponsors such

All 4 Releases


More Releases for Health

Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025 This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and
Digital Therapeutics Market 2018 Global Key Player Analysis - Omada Health, Twin …
New Intelligence Report on “Digital Therapeutics Market to 2025” is recently published by The Insight Partners. The report aims to provide leading industry players with information such as company profiles, products and services offered, financial information of last 3 yesars, key development in past five years North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc. The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing